Sun Pharmaceutical Industries Limited has entered into a definitive agreement to acquire all outstanding shares of Organon & Co. in an all-cash transaction valued at $11.75 billion. Under the terms, Sun Pharma will pay US$14.00 per share, marking one of the largest acquisitions by an Indian pharmaceutical company. The transaction has already received approval from the boards of both companies and remains subject to customary regulatory clearances and approval from Organon’s shareholders.

Strong Presence in Women’s Health and Biosimilars

Organon, which was spun off from Merck & Co. in 2021, has built a strong global presence across 140 countries. The company is widely recognised for its leadership in women’s health, supported by a portfolio of more than 70 products spanning women’s health, biosimilars, and general medicines.

Additionally, Organon operates six manufacturing facilities across the European Union and emerging markets, reinforcing its global scale and supply capabilities. Its key markets include the United States, Europe, China, Canada, and Brazil.

Strategic Fit: Strengthening Innovation and Generics Portfolio

The acquisition aligns closely with Sun Pharma’s strategy to expand its Innovative Medicines business while reinforcing its leadership in established brands and branded generics. At the same time, the deal enables Sun Pharma to enter the biosimilars segment as a top-10 global player. By integrating Organon’s diversified portfolio and global footprint, Sun Pharma aims to unlock long-term value and strengthen its competitive positioning across multiple therapeutic segments.

Post-Acquisition Scale and Market Positioning

Following the completion of the transaction, the combined entity is expected to achieve significant scale and strategic advantages:

*Rank among the top 25 global pharmaceutical companies with combined revenues of approximately US$12.4 billion

*Strengthen its position in established brands and branded generics

*Increase contribution from innovative medicines to around 27% of revenues

*Emerge as a top 3 player in global women’s health

*Become the 7th largest biosimilar company worldwide

*Expand presence to 150 countries, with 18 key markets generating over US$100 million each

The combined company is expected to significantly enhance its EBITDA and cash flow, supporting deleveraging despite a post-transaction net debt/EBITDA ratio of 2.3x.

Leadership Commentary

Dilip Shanghvi, Executive Chairman of Sun Pharma, emphasised that the acquisition represents a major step in advancing the company’s vision of expanding global access to healthcare. He noted that Organon’s portfolio and capabilities complement Sun Pharma’s strengths and will help build a more diversified and resilient business.

Managing Director Kirti Ganorkar highlighted that the deal will strengthen Sun Pharma’s position as a global partner for product launches and acquisitions. He added that the company will prioritise smooth integration, business continuity, and long-term value creation, while also leveraging potential revenue synergies.

Carrie Cox, Executive Chair of Organon, stated that the all-cash transaction delivers immediate and compelling value to shareholders. She also expressed confidence in Sun Pharma’s ability to support Organon’s global operations and advance its mission of improving access to essential medicines.

Creating a Stronger Global Healthcare Platform

As per the press release, the acquisition marks a transformative move for Sun Pharma. By combining innovation, scale, and global reach, the company is well-positioned to accelerate growth across key therapeutic areas, including women’s health and biosimilars, while reinforcing its role in the global pharmaceutical landscape.

Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration for its Abbreviated New Drug Application (ANDA) for Fingolimod Capsules, 0.5 mg. This approval enables the company to market the product in the United States, further strengthening its presence in the regulated generics market.

Therapeutic Equivalence to Reference Drug

The approved formulation is therapeutically equivalent to the reference listed drug (RLD), Gilenya Capsules, 0.5 mg, developed by Novartis Pharmaceuticals Corporation. As a result, Alembic can offer a cost-effective alternative while maintaining the same safety and efficacy standards.

Indication: Treatment for Multiple Sclerosis

Fingolimod is a sphingosine 1-phosphate receptor modulator indicated for treating relapsing forms of Multiple Sclerosis. This includes clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive disease in patients aged 10 years and older. Patients and healthcare providers are advised to refer to the product label for detailed usage guidelines.

Market Opportunity and Growth Potential

According to IQVIA data, Fingolimod Capsules, 0.5 mg, recorded an estimated market size of approximately US$145 million for the 12 months ending December 2025. Therefore, this approval presents a meaningful commercial opportunity for Alembic in the US generics segment.

Strong ANDA Portfolio Expansion

With the latest approval, Alembic continues to expand its regulatory portfolio. The company now holds a cumulative total of 237 ANDA approvals from the USFDA, including 219 final approvals and 18 tentative approvals. As per the press release, the milestone reinforces Alembic’s strategy to strengthen its footprint in high-value therapeutic segments while delivering affordable medicines to global markets.

Balrampur Chini Mills approved the establishment of a lactogypsum processing plant in Kumbhi, Uttar Pradesh, as part of its strategy to enhance sustainability and value addition. The initiative marks a significant step in leveraging by-products from its upcoming Polylactic Acid (PLA) project, thereby strengthening its integrated operations model.

Turning Industrial By-Products into Commercial Opportunity

With an investment of up to ₹160 crore, the facility will utilise lactogypsum—a by-product generated during PLA production—to manufacture gypsum boards. As a result, the project will reduce industrial waste while promoting environmentally responsible manufacturing practices.

The plant is expected to produce around 76 lakh gypsum boards annually, catering to rising demand from the construction and infrastructure sectors. By converting waste into commercially viable products, BCML aims to improve resource efficiency while diversifying its revenue streams.

Timeline and Growth Outlook

The company expects to commence commercial operations at the plant by December 2027. This timeline positions BCML as a forward-looking player focused on sustainable industrial development and circular economy practices.

Fundraising to Support Expansion Plans

In addition to the plant approval, BCML’s Board has cleared a ₹450 crore fundraise through a preferential equity issue, subject to shareholder approval. This move will help strengthen the company’s balance sheet and support its ongoing expansion initiatives.

Revised Capex for PLA Project

The company has revised the capital expenditure for its Polylactic Acid (PLA) project to approximately ₹3,080 crore, reflecting updated project requirements and cost adjustments. As reported by projectstoday.ai, together, these initiatives highlight BCML’s commitment to integrating sustainability with growth, while building long-term value across its operations.

Oil and Natural Gas Corporation (ONGC) approved the formation of an Integrated Petrochemicals Marketing and Trading Joint Venture (JV) with its group companies. Through this move, the company aims to build scale in petrochemical marketing while improving operational efficiency across its portfolio.

Initially, ONGC will invest ₹25 crore in the JV. The platform will focus on optimising petrochemical sales by reducing logistics costs, enhancing pricing strategies, and enabling better product-grade optimisation. In addition, the JV is expected to unlock third-party sales opportunities and reduce India’s dependence on petrochemical imports.

Regulatory Clearances and Government Oversight

However, the proposed JV remains subject to regulatory approvals, including clearance from the Department of Investment and Public Asset Management. This step is crucial, as ONGC operates as a state-owned enterprise, and such downstream ventures require alignment with government policies governing public sector undertakings.

Strengthening Gas Infrastructure in North East India

Alongside its petrochemicals strategy, ONGC has also approved financial support for the Duliajan Feeder Line project under Indradhanush Gas Grid Limited. The project forms a critical part of the North East Gas Grid, aimed at improving energy connectivity in the region. Specifically, ONGC has sanctioned an equity investment of up to ₹79.48 crore and a corporate guarantee of up to ₹185.45 crore for IGGL. These approvals underscore the company’s commitment to strengthening India’s natural gas infrastructure.

Collaborative PSU Effort for Energy Connectivity

IGGL operates as a joint venture involving leading public sector companies, including Indian Oil Corporation, GAIL, Oil India, and Numaligarh Refinery Ltd. Together, these entities are working to expand natural gas pipeline infrastructure across the North East. Consequently, the Duliajan feeder line plays a strategic role in integrating regional pipelines with the national gas grid, thereby enhancing energy access and supporting industrial development.

Aligning with National Energy Priorities

Overall, ONGC’s twin decisions highlight a balanced strategy. On one hand, the company is strengthening its petrochemicals marketing capabilities to drive revenue growth. On the other, it is actively supporting critical infrastructure projects that align with the government’s vision of expanding gas connectivity in underserved regions. As reported by multibagg.ai, by combining commercial expansion with infrastructure development, ONGC continues to reinforce its role in India’s evolving energy landscape.

ReNew Energy Global commenced construction of a 6.5 GW solar ingot and wafer manufacturing facility in Andhra Pradesh, marking a significant step toward strengthening India’s domestic solar supply chain. With an investment of ₹4,200 crore, the project is expected to be commissioned within 24 months. Notably, it is among the early greenfield facilities in India dedicated to producing solar ingots and wafers—critical components in photovoltaic manufacturing.

Boosting Regional Development

The project is set to contribute greatly towards local economic development. It forms part of ReNew’s broader ₹82,000 crore investment commitment in Andhra Pradesh, aimed at expanding renewable energy capacity and manufacturing infrastructure in the state.

Driving Backward Integration in Solar Value Chain

By producing wafers and ingots domestically, ReNew aims to enhance backward integration across its solar operations. As a result, the company expects to reduce reliance on imports and build a more resilient and self-sufficient supply chain.

Aligning with Andhra Pradesh’s Green Energy Vision

The state government has positioned the project within its larger strategy to accelerate renewable energy growth and industrial expansion. Andhra Pradesh has set an ambitious target of developing 160 GW of green energy capacity, with proposals already in place for nearly 90 GW. At the same time, the government continues to attract investments in energy and infrastructure while improving ease of doing business and expediting project approvals.

Supporting Policy and Future Readiness

ReNew’s manufacturing expansion aligns closely with evolving policy frameworks, including the extension of the Approved List of Models and Manufacturers (ALMM) to cover wafers and ingots from 2028. This policy shift is expected to further encourage domestic production and reduce import dependency.

Expanding Manufacturing and Renewable Portfolio

ReNew operates 6.5 GW of solar module manufacturing capacity, and its solar cell capacity is expected to reach the same level by December 2026. In parallel, the company is developing a large hybrid renewable energy project in Anantapur district, with an investment of approximately ₹22,000 crore. This project will integrate solar, wind, and battery storage to deliver reliable clean energy.

Strengthening Integrated Clean Energy Ecosystem

ReNew has maintained a strong presence in Andhra Pradesh since 2015 through its wind and solar assets. With the addition of this new facility, the company aims to create a more integrated clean energy ecosystem—linking manufacturing capabilities with power generation. As reported by manufactutingtodayindia.com, the initiative will support India’s transition to sustainable energy while boosting industrial growth in the region.

US has imposed a preliminary anti-dumping duty of 123.04% on solar cells and modules imported from India, significantly tightening pressure on an already constrained export segment. The decision follows an investigation by the US Department of Commerce involving companies such as Mundra Solar Energy and Premier Energies.

The new duty comes in addition to existing countervailing duties exceeding 125%, pushing the total tariff burden on Indian solar exports to over 200%. As a result, industry participants warn that exporting to the US market has become commercially unviable under the current structure.

‘Critical Circumstances’ Clause Intensifies Impact

In a further escalation, US authorities invoked “critical circumstances” in their findings. Consequently, they extended the suspension of liquidation to shipments made up to 90 days prior to the official notification. Additionally, in certain cases, authorities applied adverse inference, citing alleged non-cooperation by companies in submitting required data. This has further complicated the situation for Indian exporters.

Industry Bodies Challenge the Ruling

Indian industry associations have strongly opposed the preliminary findings. The National Solar Energy Federation of India has already initiated formal representations, arguing that the ruling lacks a sound and evidence-based foundation.

The Indian Solar Manufacturers Association has indicated that it will contest the decision during the final determination stage and, if necessary, through subsequent legal and trade proceedings. These coordinated efforts highlight growing resistance from the domestic solar industry.

Despite the sharp tariff hike, the immediate impact on Indian exports could be partially mitigated. In recent years, manufacturers have actively diversified their market presence, increasing exports to regions such as Europe and West Asia. Therefore, while the US remains an important market, reduced dependency may help companies navigate the current disruption more effectively.

Implications for India–US Trade Talks

The development comes at a sensitive time, as India and the United States continue discussions on a potential bilateral trade agreement. Industry stakeholders believe the tariff decision could influence ongoing negotiations and reshape trade dynamics within the renewable energy sector.

Rising Trade Frictions Amid Growing Global Demand

The imposition of steep duties underscores persistent trade tensions in the global solar sector. As reported by manufacturingtodayindia.com, at the same time, demand for renewable energy equipment continues to rise worldwide, creating a complex landscape where protectionist measures and clean energy ambitions increasingly intersect.

Ashoka University’s Ashoka Centre for a People-Centric Energy Transition (ACPET) forged a strategic partnership with the Technology Innovation in Exploration & Mining (TEXMiN) Foundation, a Department of Science and Technology-backed initiative at IIT (ISM) Dhanbad. Through this collaboration, both institutions aim to accelerate research and policy development in critical minerals and clean energy systems.

Focus on Research, Policy, and Capacity Building

The partnership will actively drive evidence-based research, policy advocacy, and capacity building across the entire energy–minerals value chain. Specifically, it will address key priorities such as identifying critical minerals, enabling their sustainable extraction, strengthening supply chains, and repurposing mines for renewable energy generation and ecological restoration.

Blending Policy Expertise with Advanced Mining Technologies

By combining ACPET’s strengths in energy transition policy and community-focused research with TEXMiN’s advanced technological capabilities, the collaboration creates a powerful synergy. TEXMiN brings expertise in AI, IoT, robotics, and cyber-physical systems aligned with Mining 4.0, thereby enhancing innovation in mining exploration and operations.

Assessing Environmental and Climate Impacts

In addition, the partnership will place strong emphasis on analysing environmental and climate risks in mining regions. This includes evaluating carbon footprints, land and water usage, and broader ecological impacts. As a result, the initiative aims to promote more sustainable and responsible mining practices.

Advancing People-Centric and Just Transition Frameworks

The collaboration will develop people-centric frameworks that connect mineral resource governance with clean energy deployment. It will also focus on enabling a just transition for mining-dependent communities, ensuring that economic and social outcomes remain inclusive and equitable.

Aligning with India’s Energy and Climate Goals

The initiative closely aligns with India’s national priorities, including strengthening energy security, reducing dependence on imported critical minerals, and achieving long-term climate goals such as Net Zero 2070. Furthermore, it supports the broader vision of building a resilient and self-reliant industrial ecosystem.

Driving Collaboration and Knowledge Exchange

Both institutions will jointly undertake research projects, technical reports, and policy briefs while actively pursuing national and international funding opportunities. To foster knowledge exchange, they will organise workshops, conferences, and academic collaborations, including student and faculty exchange programmes.

Building End-to-End Sustainable Solutions

As reported by manufacturingtodayindia.com, over the next three years, the partnership is expected to deliver integrated, end-to-end solutions across the clean energy and mining sectors. Ultimately, it will prioritise sustainability, technological innovation, and community-centric outcomes, positioning India for a stronger and more secure energy future.

Scientists at SIBUR’s PolyLab Applied Research Center developed and successfully tested a novel adhesive solution for the agricultural sector. Based on a styrene-acrylic dispersion, this innovation is designed to protect crop pods from premature cracking, thereby reducing losses and significantly improving harvesting efficiency.

Driving Efficiency in Modern Agriculture

SIBUR continues to prioritise the use of advanced synthetic materials to improve crop cultivation and harvest preservation. In collaboration with agricultural stakeholders, the company actively develops practical, scalable solutions that not only minimise losses but also enhance overall productivity and sustainability across the agro-industrial value chain.

How the Adhesive Technology Works

The newly developed adhesive targets cruciferous crops such as rapeseed and mustard, as well as legumes including peas, soybeans, lentils, and chickpeas. When applied via standard spraying equipment, the formulation dries quickly to form a uniform polymer film over the pod surface.

As a result, this protective layer prevents premature pod opening caused by environmental stressors such as wind, temperature fluctuations, and rainfall. Moreover, the adhesive is moisture-resistant, plant-safe, and does not compromise seed quality. Importantly, it has no adverse impact on soil health, the environment, or human safety.

Enhancing Harvesting Efficiency

In addition to reducing crop losses, the adhesive improves harvesting operations. Farmers can adopt direct combining methods without requiring additional field preparation. This not only streamlines operations but also reduces the risk of equipment clogging, leading to smoother and more efficient harvesting processes.

Proven Results from Field Trials

According to Kermen Bovaldinova, Director of Product Development at SIBUR PolyLab, field trials have demonstrated strong performance outcomes. Tests conducted on winter and spring rapeseed, peas, and soybeans revealed a notable increase in biological yield due to improved seed retention.

For instance, seed survival increased by up to 28% in rapeseed and up to 15% in peas. At the same time, pod cracking rates dropped significantly—from 12.50% to 3.74% in rapeseed and from 8.20% to 2.02% in peas—when compared to untreated plots.

Supporting Climate-Resilient Farming

By enabling better control over weather-related risks, the use of such synthetic materials enhances the predictability of harvest outcomes. SIBUR has designed the adhesive with real-world farming conditions in mind, ensuring ease of use and adaptability across diverse agricultural environments.

Scaling Up for Wider Adoption

Encouraged by these results, SIBUR plans to expand testing across multiple climate zones and farming systems. If large-scale trials confirm its effectiveness, the pod adhesive could emerge as a key technological tool for reducing crop losses and boosting farm productivity. The company aims to make this solution widely available to agricultural producers across Russia.

Expanding SIBUR’s Agro-Industrial Portfolio

As reported by polymerupdate.com, SIBUR already offers a broad range of polymer-based solutions for the agro-industrial sector. These applications span crop production, livestock farming, land reclamation, and fisheries. Through continuous innovation, the company is strengthening the sector’s sustainability, competitiveness, and export potential.

Praj Industries unveiled an Advanced Precision Fermentation Lab at its innovation hub, Praj Matrix, marking a significant step toward next-generation industrial biotechnology and low-carbon biomanufacturing. The announcement was made during the 18th Praj Matrix Foundation Day.

Driving Next-Gen Biomanufacturing with AI and Precision Fermentation

The newly established lab will focus on AI-enabled precision fermentation and advanced bioprocessing technologies. By doing so, it aims to:

*Improve process efficiency

*Reduce scale-up risks

*Enhance operational reliability

Additionally, the facility will support a wide range of industries, including pharmaceuticals, food, cosmetics, biofuels, and beverages. It will also strengthen the capabilities of Praj HiPurity Systems, Praj’s Mumbai-based subsidiary known for precision fermenters and ultra-pure water systems.

Strong Academia-Industry Collaboration

To further accelerate innovation, Praj has signed a Memorandum of Understanding (MoU) with Biotechnology Research and Innovation Council – National Centre for Cell Science (BRIC-NCCS).

This collaboration will:

*Advance bioprocess development and scalable manufacturing

*Enable discovery of novel biomolecules and microbial strains

*Provide hands-on training and internships for PhD scholars

*Promote joint research and long-term academia-industry partnerships

As a result, the initiative is expected to bridge the gap between laboratory research and commercial-scale biomanufacturing.

Aligned with India’s BioE3 Strategy

The initiative aligns with the Government of India’s BioE3 (Biotechnology for Economy, Environment, and Employment) vision, led by the Department of Biotechnology. Speaking at the event, Rajesh S. Gokhale, Secretary, DBT, highlighted that strong academia-industry linkages and a skilled workforce will be key drivers of India’s bioeconomy growth.

Leadership Perspective: Scaling Innovation

Pramod Chaudhari emphasised that the new lab integrates biology, engineering, and digital technologies to create scalable, sustainable solutions. He added that the initiative will accelerate the transition from scientific discovery to commercial deployment.

Praj Matrix: A Hub for Bio-Innovation

Over the years, Praj Matrix has emerged as a core innovation engine for Praj Industries. Its research spans:

*Biofuels and renewable chemicals (biopolymers, biobitumen)

*Industrial biotechnology and enzyme development

*Advanced water and wastewater treatment solutions

Backed by over 90 scientists, multiple specialised labs, and a strong intellectual property portfolio with 300+ patents, Praj Matrix continues to develop technologies that are scaled globally.

Accelerating India’s Bio-Based Economy

With the latest development, Praj reinforces its commitment to collaborative innovation by bringing together academia, industry, and policymakers. As reported by chinimandi.com, as India pushes toward a sustainable and self-reliant bioeconomy, initiatives like this advanced fermentation lab will play a crucial role in driving low-carbon manufacturing, innovation, and global competitiveness.